This recent sighting has caused a lot of debate!
When it comes to creating a vision to lead by, building a culture and supporting a team’s career development, Takeda leaders know what they’re doing. Being passionate about leadership and what you do helps too, said Head…
The agreement is one of the largest single-asset deals of all time
MIT-Takeda Program researchers have developed a physics and machine learning technique to enhance the manufacturing process of pharmaceutical pills and powders. Their method, called PEACE, involves using a laser and machine learning to measure particle size distribution, increasing efficiency, reducing failed batches, and making the process more sustainable and cost-effective. A collaborative research team…
BOSTON, Mass. -- By Lee Han-soo/Korea Biomedical Review correspondent -- Takeda Pharmaceuticals, the first Asian-based company to secure a spot among the 10 largest global pharma companies by sales, has redefined its research and development (R&D) strategy for groundbreaking discoveries and cutting-edge therapies, the company’s head of R&D said.
Korea Biomedical Review met with Andy…
When medical companies manufacture the pills and tablets that treat any number of illnesses, aches, and pains, they need to isolate the active pharmaceutical ingredient from a suspension and dry it. The process requires a human operator to monitor an industrial dryer, agitate the material, and watch for the compound to take on the right…
SEATTLE , March 21, 2023 /PRNewswire/ -- Arzeda, the industry-leading Protein Design Company™, announced a collaboration with Takeda aimed at deploying AI-based protein design to optimize the properties of protein biologics.
The collaboration will allow Takeda to leverage Arzeda's Intelligent Protein Design Technology™, which has the potential to accelerate the optimization of proteins…
Takeda has
Data and technology are front and center for global pharma giant Takeda. Find out all from head of global talent acquisition Jimmy Zhang.
In 2020, the School of Engineering and Takeda Pharmaceutical Company launched the MIT-Takeda Program, which aims to leverage the experience of both entities to solve problems at the intersection of health care, medicine, and artificial intelligence. Since the program began, teams have devised mechanisms to reduce manufacturing time for certain pharmaceutical products, submitted a patent…
The MIT-Takeda Program, a collaboration between MIT’s School of Engineering and Takeda Pharmaceuticals Company, fuels the development and application of artificial intelligence capabilities to benefit human health and drug development. Part of the Abdul Latif Jameel Clinic for Machine Learning in Health, the program coalesces disparate disciplines, merges theory and practical implementation, combines algorithm and…
The BioPIPS project is in line with Singapore’s wider “Manufacturing 2030” program, which aims to boost the country’s manufacturing by 50%. Credit: warut pothikit / Shutterstock.
…